KRYS |
Krystal Biotech, Inc. |
5.24B |
3.32% |
|
|
|
|
|
182.34 |
2.38% |
41.44% |
35.92% |
---|
RNA |
Avidity Biosciences, Inc. |
5.15B |
3.30% |
|
|
|
|
|
43.20 |
-1.04% |
70.29% |
13.46% |
---|
CORT |
Corcept Therapeutics Incorporated |
5.85B |
3.23% |
|
|
|
|
|
55.79 |
-0.53% |
69.41% |
31.55% |
---|
ACLX |
Arcellx, Inc. |
4.74B |
3.01% |
|
|
|
|
|
87.57 |
0.40% |
67.52% |
40.22% |
---|
CRNX |
Crinetics Pharmaceuticals, Inc. |
5.30B |
2.88% |
|
|
|
|
|
57.12 |
1.87% |
61.71% |
32.45% |
---|
IMVT |
Immunovant, Inc. |
3.89B |
2.84% |
|
|
|
|
|
26.51 |
1.30% |
34.00% |
56.52% |
---|
ALKS |
Alkermes plc |
4.49B |
2.81% |
|
|
|
|
|
27.75 |
-0.57% |
36.43% |
56.97% |
---|
DNLI |
Denali Therapeutics Inc. |
3.50B |
2.46% |
|
|
|
|
|
24.32 |
-0.41% |
80.73% |
64.16% |
---|
MRUS |
Merus N.V. |
3.08B |
2.34% |
|
|
|
|
|
45.03 |
4.89% |
71.47% |
24.99% |
---|
FOLD |
Amicus Therapeutics, Inc. |
2.84B |
2.20% |
|
|
|
|
|
9.52 |
-0.78% |
42.55% |
39.59% |
---|
PTCT |
PTC Therapeutics, Inc. |
3.34B |
2.08% |
|
|
|
|
|
43.33 |
3.27% |
71.55% |
16.62% |
---|
XENE |
Xenon Pharmaceuticals Inc. |
3.06B |
2.00% |
|
|
|
|
|
40.13 |
2.01% |
33.88% |
13.54% |
---|
EWTX |
Edgewise Therapeutics, Inc. |
3.05B |
2.00% |
|
|
|
|
|
32.26 |
0.97% |
106.11% |
26.75% |
---|
ZLAB |
Zai Lab Limited |
2.78B |
1.97% |
|
|
|
|
|
25.83 |
-1.53% |
67.78% |
22.32% |
---|
PTGX |
Protagonist Therapeutics, Inc. |
2.47B |
1.80% |
|
|
|
|
|
41.41 |
1.86% |
63.50% |
25.80% |
---|
MLTX |
MoonLake Immunotherapeutics |
3.23B |
1.78% |
|
|
|
|
|
51.14 |
2.64% |
50.13% |
10.90% |
---|
VRNA |
Verona Pharma plc |
3.12B |
1.77% |
|
|
|
|
|
38.10 |
-1.93% |
56.78% |
9.25% |
---|
AGIO |
Agios Pharmaceuticals, Inc. |
3.18B |
1.69% |
|
|
|
|
|
55.83 |
2.22% |
53.89% |
65.61% |
---|
APGE |
Apogee Therapeutics, Inc. |
2.55B |
1.68% |
|
|
|
|
|
43.50 |
-3.42% |
64.40% |
45.96% |
---|
CGON |
CG Oncology, Inc. Common stock |
2.19B |
1.64% |
|
|
|
|
|
32.61 |
1.15% |
88.78% |
35.64% |
---|
GERN |
Geron Corporation |
2.43B |
1.63% |
|
|
|
|
|
4.03 |
0.88% |
53.33% |
7.87% |
---|
IDYA |
IDEAYA Biosciences, Inc. |
2.31B |
1.63% |
|
|
|
|
|
26.75 |
4.72% |
96.69% |
56.95% |
---|
VERA |
Vera Therapeutics, Inc. |
2.99B |
1.60% |
|
|
|
|
|
47.23 |
3.24% |
52.84% |
9.07% |
---|
ACAD |
ACADIA Pharmaceuticals Inc. |
2.70B |
1.58% |
|
|
|
|
|
16.25 |
-0.12% |
60.49% |
33.75% |
---|
VCEL |
Vericel Corporation |
2.79B |
1.43% |
|
|
|
|
|
56.54 |
-1.27% |
60.64% |
22.42% |
---|
AKRO |
Akero Therapeutics, Inc. |
2.15B |
1.42% |
|
|
|
|
|
30.86 |
0.72% |
43.68% |
15.24% |
---|
KROS |
Keros Therapeutics, Inc. |
2.20B |
1.41% |
|
|
|
|
|
54.36 |
0.40% |
60.94% |
32.74% |
---|
SLNO |
Soleno Therapeutics, Inc. |
2.37B |
1.38% |
|
|
|
|
|
54.92 |
0.16% |
122.85% |
75.16% |
---|
LBPH |
Longboard Pharmaceuticals, Inc. |
2.33B |
1.33% |
|
|
|
|
|
59.76 |
-0.02% |
40.70% |
-0.20% |
---|
ARVN |
Arvinas, Inc. |
1.72B |
1.24% |
|
|
|
|
|
25.09 |
10.58% |
85.49% |
40.30% |
---|
MIRM |
Mirum Pharmaceuticals, Inc. |
2.11B |
1.22% |
|
|
|
|
|
43.89 |
0.46% |
58.22% |
34.06% |
---|
MNKD |
MannKind Corporation |
1.91B |
1.20% |
|
|
|
|
|
6.91 |
0.44% |
47.11% |
30.96% |
---|
GLPG |
Galapagos NV |
1.66B |
1.20% |
|
|
|
|
|
25.16 |
-1.87% |
43.46% |
42.90% |
---|
NMRA |
Neumora Therapeutics, Inc. Common Stock |
1.55B |
1.17% |
|
|
|
|
|
9.67 |
-1.23% |
163.66% |
52.63% |
---|
CLDX |
Celldex Therapeutics, Inc. |
1.76B |
1.15% |
|
|
|
|
|
26.60 |
0.76% |
43.18% |
33.47% |
---|
NAMS |
NewAmsterdam Pharma Company N.V. |
1.85B |
1.11% |
|
|
|
|
|
20.06 |
0.25% |
206.05% |
106.50% |
---|
BCRX |
BioCryst Pharmaceuticals, Inc. |
1.55B |
1.08% |
|
|
|
|
|
7.50 |
2.74% |
50.80% |
12.56% |
---|
TARS |
Tarsus Pharmaceuticals, Inc. |
1.79B |
1.08% |
|
|
|
|
|
46.79 |
0.45% |
97.91% |
71.75% |
---|
SNDX |
Syndax Pharmaceuticals, Inc. |
1.33B |
1.07% |
|
|
|
|
|
15.60 |
-2.19% |
69.74% |
45.36% |
---|
IMCR |
Immunocore Holdings plc |
1.60B |
1.06% |
|
|
|
|
|
31.95 |
-1.45% |
54.90% |
35.25% |
---|
NTLA |
Intellia Therapeutics, Inc. |
1.43B |
0.96% |
|
|
|
|
|
14.03 |
6.90% |
82.03% |
58.88% |
---|
RCUS |
Arcus Biosciences, Inc. |
1.32B |
0.94% |
|
|
|
|
|
14.37 |
-1.71% |
84.51% |
32.25% |
---|
SPRY |
ARS Pharmaceuticals, Inc. |
1.32B |
0.90% |
|
|
|
|
|
13.56 |
0.07% |
71.29% |
2.17% |
---|
VRDN |
Viridian Therapeutics, Inc. |
1.60B |
0.90% |
|
|
|
|
|
20.15 |
1.82% |
55.12% |
14.55% |
---|
IRON |
Disc Medicine, Inc. |
1.88B |
0.88% |
|
|
|
|
|
63.18 |
1.01% |
64.48% |
12.20% |
---|
COGT |
Cogent Biosciences, Inc. |
1.00B |
0.88% |
|
|
|
|
|
9.06 |
-0.22% |
92.74% |
44.02% |
---|
XNCR |
Xencor, Inc. |
1.69B |
0.87% |
|
|
|
|
|
24.12 |
1.69% |
66.38% |
43.09% |
---|
KURA |
Kura Oncology, Inc. |
828.98M |
0.86% |
|
|
|
|
|
10.66 |
-33.00% |
97.11% |
34.65% |
---|
PHVS |
Pharvaris N.V. |
1.12B |
0.85% |
|
|
|
|
|
20.68 |
0.85% |
N/A |
N/A |
---|
DAWN |
Day One Biopharmaceuticals, Inc. |
1.35B |
0.84% |
|
|
|
|
|
13.35 |
-1.98% |
57.02% |
15.73% |
---|
PRAX |
Praxis Precision Medicines, Inc. |
1.37B |
0.80% |
|
|
|
|
|
73.54 |
-0.19% |
74.52% |
14.32% |
---|
AVBP |
ArriVent BioPharma, Inc. Common Stock |
897.75M |
0.72% |
|
|
|
|
|
26.73 |
-2.48% |
N/A |
N/A |
---|
APLT |
Applied Therapeutics, Inc. |
1.08B |
0.69% |
|
|
|
|
|
9.28 |
-1.64% |
246.72% |
53.63% |
---|
AUPH |
Aurinia Pharmaceuticals Inc. |
1.25B |
0.69% |
|
|
|
|
|
8.72 |
5.76% |
50.31% |
7.70% |
---|
CRGX |
CARGO Therapeutics, Inc. Common Stock |
727.59M |
0.67% |
|
|
|
|
|
15.85 |
0.19% |
N/A |
N/A |
---|
PRTA |
Prothena Corporation plc |
782.49M |
0.64% |
|
|
|
|
|
14.54 |
0.99% |
194.98% |
73.62% |
---|
PLRX |
Pliant Therapeutics, Inc. |
785.01M |
0.60% |
|
|
|
|
|
12.90 |
1.34% |
134.86% |
32.95% |
---|
LQDA |
Liquidia Corporation |
865.83M |
0.57% |
|
|
|
|
|
10.23 |
1.09% |
69.31% |
5.96% |
---|
ETNB |
89bio, Inc. |
1.00B |
0.56% |
|
|
|
|
|
8.53 |
6.88% |
53.30% |
11.50% |
---|
ANAB |
AnaptysBio, Inc. |
647.22M |
0.56% |
|
|
|
|
|
21.27 |
4.73% |
267.20% |
86.11% |
---|
REPL |
Replimune Group, Inc. |
757.38M |
0.54% |
|
|
|
|
|
11.07 |
-1.43% |
72.67% |
3.63% |
---|
DNTH |
Dianthus Therapeutics, Inc. |
606.89M |
0.52% |
|
|
|
|
|
20.51 |
-1.28% |
105.29% |
58.41% |
---|
ERAS |
Erasca, Inc. |
735.09M |
0.51% |
|
|
|
|
|
2.6000 |
-1.52% |
264.92% |
54.44% |
---|
ANNX |
Annexon, Inc. |
564.42M |
0.47% |
|
|
|
|
|
5.30 |
2.62% |
110.28% |
20.36% |
---|
OLMA |
Olema Pharmaceuticals, Inc. |
465.83M |
0.46% |
|
|
|
|
|
8.13 |
-1.81% |
158.75% |
63.08% |
---|
TRML |
Tourmaline Bio, Inc. |
589.52M |
0.45% |
|
|
|
|
|
22.99 |
-4.21% |
101.79% |
67.92% |
---|
MLYS |
Mineralys Therapeutics, Inc. |
604.18M |
0.45% |
|
|
|
|
|
12.15 |
-3.57% |
339.79% |
10.31% |
---|
YMAB |
Y-mAbs Therapeutics, Inc. |
455.95M |
0.42% |
|
|
|
|
|
10.18 |
-3.42% |
15.86% |
45.11% |
---|
IRWD |
Ironwood Pharmaceuticals, Inc. |
533.69M |
0.42% |
|
|
|
|
|
3.34 |
-5.26% |
259.43% |
59.38% |
---|
SLRN |
Acelyrin, Inc. |
435.66M |
0.42% |
|
|
|
|
|
4.37 |
-1.47% |
198.12% |
84.63% |
---|
ALLO |
Allogene Therapeutics, Inc. |
443.46M |
0.41% |
|
|
|
|
|
2.1150 |
3.17% |
366.65% |
62.66% |
---|
CELC |
Celcuity Inc. |
468.20M |
0.40% |
|
|
|
|
|
12.61 |
-1.33% |
85.29% |
49.86% |
---|
SVRA |
Savara Inc. |
553.47M |
0.40% |
|
|
|
|
|
3.23 |
3.04% |
208.60% |
1.00% |
---|
FLGT |
Fulgent Genetics, Inc. |
523.65M |
0.39% |
|
|
|
|
|
17.12 |
-0.93% |
56.56% |
78.14% |
---|
URGN |
UroGen Pharma Ltd. |
492.05M |
0.35% |
|
|
|
|
|
11.66 |
1.83% |
76.20% |
8.48% |
---|
ARCT |
Arcturus Therapeutics Holdings Inc. |
464.55M |
0.35% |
|
|
|
|
|
17.15 |
6.05% |
64.04% |
33.72% |
---|
ALT |
Altimmune, Inc. |
608.47M |
0.34% |
|
|
|
|
|
8.56 |
6.28% |
95.35% |
16.21% |
---|
FULC |
Fulcrum Therapeutics, Inc. |
163.70M |
0.34% |
|
|
|
|
|
3.04 |
1.51% |
108.13% |
49.58% |
---|
ALEC |
Alector, Inc. |
370.19M |
0.33% |
|
|
|
|
|
3.78 |
3.99% |
319.26% |
64.36% |
---|
AURA |
Aura Biosciences, Inc. |
451.42M |
0.32% |
|
|
|
|
|
9.10 |
4.02% |
312.54% |
15.26% |
---|
AVXL |
Anavex Life Sciences Corp. |
780.97M |
0.31% |
|
|
|
|
|
9.21 |
8.67% |
120.63% |
47.64% |
---|
CMPS |
COMPASS Pathways plc |
305.84M |
0.27% |
|
|
|
|
|
4.47 |
-4.08% |
228.54% |
89.98% |
---|
TBPH |
Theravance Biopharma, Inc. |
474.53M |
0.27% |
|
|
|
|
|
9.65 |
-3.21% |
47.84% |
48.54% |
---|
FDMT |
4D Molecular Therapeutics, Inc. |
372.36M |
0.27% |
|
|
|
|
|
8.06 |
-4.22% |
84.86% |
25.69% |
---|
GHRS |
GH Research PLC |
503.91M |
0.26% |
|
|
|
|
|
9.69 |
-11.55% |
381.77% |
44.06% |
---|
ALDX |
Aldeyra Therapeutics, Inc. |
292.09M |
0.21% |
|
|
|
|
|
4.91 |
3.05% |
149.50% |
30.88% |
---|
ACIU |
AC Immune SA |
325.95M |
0.19% |
|
|
|
|
|
3.27 |
0.93% |
201.13% |
43.76% |
---|
STRO |
Sutro Biopharma, Inc. |
216.04M |
0.19% |
|
|
|
|
|
2.6200 |
-1.87% |
410.22% |
19.92% |
---|
ITOS |
iTeos Therapeutics, Inc. |
297.75M |
0.19% |
|
|
|
|
|
8.15 |
3.83% |
111.18% |
32.81% |
---|
AVIR |
Atea Pharmaceuticals, Inc. |
271.55M |
0.18% |
|
|
|
|
|
3.22 |
1.74% |
117.99% |
24.00% |
---|
VNDA |
Vanda Pharmaceuticals Inc. |
287.46M |
0.17% |
|
|
|
|
|
4.93 |
0.61% |
65.42% |
30.06% |
---|
INZY |
Inozyme Pharma, Inc. |
174.73M |
0.17% |
|
|
|
|
|
2.7200 |
-2.51% |
261.22% |
20.18% |
---|
ENTA |
Enanta Pharmaceuticals, Inc. |
197.00M |
0.16% |
|
|
|
|
|
9.30 |
2.38% |
286.86% |
37.44% |
---|
KYTX |
Kyverna Therapeutics, Inc. Common Stock |
170.86M |
0.15% |
|
|
|
|
|
3.96 |
-3.87% |
576.66% |
59.38% |
---|
INXB |
Inhibrx Biosciences Inc. |
|
0.15% |
|
|
|
|
|
|
|
|
|
---|
PROK |
ProKidney Corp. |
511.95M |
0.14% |
|
|
|
|
|
1.7550 |
6.36% |
344.36% |
44.94% |
---|
ZNTL |
Zentalis Pharmaceuticals, Inc. |
229.83M |
0.13% |
|
|
|
|
|
3.23 |
3.04% |
370.15% |
70.62% |
---|
ANRO |
Alto Neuroscience, Inc. |
112.55M |
0.07% |
|
|
|
|
|
4.18 |
-2.23% |
265.84% |
10.10% |
---|
HLVX |
HilleVax, Inc. |
89.90M |
0.06% |
|
|
|
|
|
1.8050 |
0.84% |
N/A |
N/A |
---|
|
Cash and Equivalents |
|
0.01% |
|
|
|
|
|
|
|
|
|
---|